The efficacy of naftopidil in treatment of female urethral syndrome / 医学研究生学报
Journal of Medical Postgraduates
;
(12)2003.
Article
in Chinese
| WPRIM
| ID: wpr-585245
ABSTRACT
Objective:
To evaluate the efficacy and safety of Naftopidil on patients with female urethral syndrome (FUS).Methods:
Self-controlled clinical trial was performed in patients with FUS. Thirty-eight patients were treated with naftopidil tablet 25mg/po/qn for 4 weeks after one-week washout period. The effects were evaluated mainly by female urethral syndrome score (FUSS) and quality of life (QOL).Results:
FUSS began to decrease after 2 (week's) administration and decreased significantly after 4 weeks' treatment. It had statistically significant difference of FUSS and QOL after treatment compared with control (P
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Chinese
Journal:
Journal of Medical Postgraduates
Year:
2003
Type:
Article
Similar
MEDLINE
...
LILACS
LIS